102. Premature Births Lead to Halt in Maternal RSV Vaccine Study | Podcast

Sdílet
Vložit
  • čas přidán 12. 04. 2024
  • RSV is a respiratory virus that can be serious, especially for young infants. Vaccines have been developed to give to the mother so the baby might be protected during the most vulnerable period. While the data showed it worked, the GlaxoSmithKline RSV vaccine study was stopped early due to increased premature deliveries. Let’s talk about it!
    -------
    Episode Sources:
    www.medpagetoday.com/infectio... (czcams.com/users/redirect?even...) www.nejm.org/doi/full/10.1056... (czcams.com/users/redirect?even...) www.ncbi.nlm.nih.gov/books/NB... (czcams.com/users/redirect?even...)
    -------
    Please SUBSCRIBE for new videos throughout the week!
    bit.ly/3xhijVf (czcams.com/users/redirect?even...)
    Let's connect:
    Website: DrDavidMD.com/ (czcams.com/users/redirect?even...)
    FB: / pagingdrdavidmd (czcams.com/users/redirect?even...)
    IG: / pagingdrdavidmd (czcams.com/users/redirect?even...)
    LI: / drdavidmd (czcams.com/users/redirect?even...)
    TW: / pagingdrdavidmd (czcams.com/users/redirect?even...)
    --------
    Become a patron to access exclusive content. Click below:
    / drdavidmd (czcams.com/users/redirect?even...)
    Dr. David is an independent thinker who draws from more than 25 years of clinical experience. He relies on a broad range of evidence-based information to provide his best possible guidance. Dr. David's thoughts and opinions may shift as the data evolves. Information he shares with the public is not intended as a substitute for professional medical advice, diagnosis, or treatment. All content is informative and does not replace the need for consultation with qualified health professionals.

Komentáře • 1